Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 10, 2025 08:00 ET | Source: 22nd Century Group, Inc.

22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less

Extensive Clinical Data Continues to Demonstrate VLN® Reduced Nicotine Content Tobacco Helps Reduce Smoking and Increase Quit Attempts Growing List of VLN® Based Cigarette Brands Bring Non-Addictive...
June 18, 2025 08:00 ET | Source: PharmaTher Holdings Ltd.

PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders, and National Security Applications

TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of...
October 23, 2024 08:00 ET | Source: PharmaTher Holdings Ltd.

PharmaTher Receives Complete Response Letter from the U.S. Food and Drug Administration for Ketamine Abbreviated New Drug Application

TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the U.S. Food...
May 07, 2024 10:00 ET | Source: Dipharma Francis S.r.l

Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA

Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process.
March 23, 2024 10:15 ET | Source: UsAgainstAlzheimer's

Congress Passes Bills Making Major Investments in Alzheimer’s

Congress passes major investments in the fight against Alzheimer’s.
March 14, 2024 17:50 ET | Source: The Rosen Law Firm PA

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INMD

NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and...
March 08, 2024 07:55 ET | Source: UsAgainstAlzheimer's

FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s

WASHINGTON, March 08, 2024 (GLOBE NEWSWIRE) -- The maker of donanemab, Eli Lilly, announced today that the Food and Drug Administration (FDA) will convene an advisory committee to consider the...
January 04, 2024 07:43 ET | Source: Emergen Research

Smart Pills Market Size Worth USD 1.84 Billion in 2032 | Emergen Research

Vancouver, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The global smart pills market size was USD 0.60 Billion in 2022 and is expected to register a rapid revenue CAGR of 12.0% during the forecast period...
January 01, 2024 13:55 ET | Source: The Rosen Law Firm PA

BCLI FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm – BCLI

NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between...
December 11, 2023 08:00 ET | Source: NeuroOne Medical Technologies Corp

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System

First FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control; Marks the Company’s third...

Next Page keyboard_arrow_right